What is the starting dose of Gemfibrozil (Lopid)?

There are no official guidelines to assist in answering this question. I will search for relevant research papers instead.

The FDA Drug Labels for gemfibrozil (PO) do not address this question.

From the Research

Dosage Information

• The starting dose of Gemfibrozil (Lopid) is not explicitly stated in the provided studies, but the typical daily doses used in the studies are:
  • 600mg twice daily 1
  • 1200mg once daily 2
  • 1200mg/day 3, 4
• The studies suggest that Gemfibrozil can be effective in reducing triglycerides and increasing HDL cholesterol at these doses, but the optimal starting dose may depend on individual patient factors.

Study Findings

• Gemfibrozil has been shown to be effective in reducing triglycerides and increasing HDL cholesterol in patients with dyslipidemia 5, 1, 2, 3, 4
• The drug has been compared to other lipid-lowering agents, such as ciprofibrate, and has been found to be similarly effective in reducing triglycerides and increasing HDL cholesterol 4

Patient Populations

• Gemfibrozil has been studied in various patient populations, including adults with dyslipidemia 5, 1, 2, 4 and pediatric patients with metabolic syndrome 3
• The drug has been found to be effective and relatively safe in these populations, although the optimal dose and duration of treatment may vary depending on individual patient factors.